Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-30 @ 1:44 PM
Study NCT ID:
NCT06953960
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2025-04-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2030-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-17
First Submit QC Date:
None
Study First Post Date:
2025-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-19
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED